Imaging of a glucose analog, calcium and NADH in neurons and astrocytes: Dynamic responses to depolarization and sensitivity to pioglitazone

Cell Calcium

Volumn 50, Issue 6, 2011, Pages 548-558

  Pancani, Tristano ^a   Anderson, Katie L ^a   Porter, Nada M ^a   Thibault, Olivier ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Brain aging; Calcium signaling; Glycolysis imaging; Metabolic dysregulation; Thiazolidinedione

Indexed keywords

2 [N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO] 2 DEOXYGLUCOSE; CALCIUM; FURA 2; GLUCOSE DERIVATIVE; PIOGLITAZONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; DEPOLARIZATION; DRUG SENSITIVITY; FEMALE; FETUS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HIPPOCAMPUS; IMAGING; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 82855175141     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.09.002     Document Type: Article

References (90)

1. Mata M., Fink D.J., Gainer H., Smith C.B., Davidsen L., Savaki H., Schwartz W.J., Sokoloff L. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem. 1980, 34:213-215.
2. Alle H., Roth A., Geiger J.R. Energy-efficient action potentials in hippocampal mossy fibers. Science 2009, 325:1405-1408.
3. Hu Y., Wilson G.S. Rapid changes in local extracellular rat brain glucose observed with an in vivo glucose sensor. J. Neurochem. 1997, 68:1745-1752.
4. McNay E.C., Fries T.M., Gold P.E. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:2881-2885.
5. Fox P.T., Raichle M.E., Mintun M.A., Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988, 241:462-464.
6. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10625-10629.
7. Jolivet R., Allaman I., Pellerin L., Magistretti P.J., Weber B. Comment on recent modeling studies of astrocyte-neuron metabolic interactions. J. Cereb. Blood Flow Metab. 2010, 30:1982-1986.
8. Roberts E.L., Chih C.P. Age-related alterations in energy metabolism contribute to the increased vulnerability of the aging brain to anoxic damage. Brain Res. 1995, 678:83-90.
9. Rapoport S.I. Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease. Neurotox. Res. 2003, 5:385-398.
10. Salkovic-Petrisic M., Osmanovic J., Grunblatt E., Riederer P., Hoyer S. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta. J. Alzheimers Dis. 2009, 18:729-750.
11. Mosconi L., De Santi S., Li J., Tsui W.H., Li Y., Boppana M., Laska E., Rusinek H., de Leon M.J. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging 2008, 29:676-692.
12. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998, 50:164-168.
13. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
14. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006, 5:64-74.
15. de la Monte S.M., Tong M., Lester-Coll N., Plater M., Wands J.R. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J. Alzheimers Dis. 2006, 10:89-109.
16. Gasparini L., Netzer W.J., Greengard P., Xu H. Does insulin dysfunction play a role in Alzheimer's disease?. Trends Pharmacol. Sci. 2002, 23:288-293.
17. Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur. J. Pharmacol. 2004, 490:115-125.
18. Watson G.S., Cholerton B.A., Reger M.A., Baker L.D., Plymate S.R., Asthana S., Fishel M.A., Kulstad J.J., Green P.S., Cook D.G., Kahn S.E., Keeling M.L., Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am. J. Geriatr. Psychiatry 2005, 13:950-958.
19. Risner M.E., Saunders A.M., Altman J.F., Ormandy G.C., Craft S., Foley I.M., Zvartau-Hind M.E., Hosford D.A., Roses A.D. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 2006, 6:246-254.
20. Sato T., Hanyu H., Hirao K., Kanetaka H., Sakurai H., Iwamoto T. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol. Aging 2011, 32:1626-1633.
21. Dello Russo C., Gavrilyuk V., Weinberg G., Almeida A., Bolanos J.P., Palmer J., Pelligrino D., Galea E., Feinstein D.L. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J. Biol. Chem. 2003, 278:5828-5836.
22. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53:409-435.
23. Grillo C.A., Piroli G.G., Hendry R.M., Reagan L.P. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 2009, 1296:35-45.
24. Hauner H. The mode of action of thiazolidinediones. Diabetes Metab. Res. Rev. 2002, 18(Suppl. 2):S10-S15.
25. Pancani T., Phelps J.T., Searcy J.L., Kilgore M.W., Chen K.C., Porter N.M., Thibault O. Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons. J. Neurochem. 2009, 109:1800-1811.
26. Zhao X., Ou Z., Grotta J.C., Waxham N., Aronowski J. Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity. Brain Res. 2006, 1073-1074:460-469.
27. Camacho I.E., Serneels L., Spittaels K., Merchiers P., Dominguez D., De Strooper B. Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J. Neurosci. 2004, 24:10908-10917.
28. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 2000, 20:558-567.
29. Heneka M.T., Sastre M., Dumitrescu-Ozimek L., Hanke A., Dewachter I., Kuiperi C., O'Banion K., Klockgether T., Van Leuven F., Landreth G.E. Acute treatment with the PPAR{gamma} agonist pioglitazone and ibuprofen reduces glial inflammation and A{beta}1-42 levels in APPV717I transgenic mice. Brain 2005, 128:1442-1453.
30. Landreth G.E., Heneka M.T. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol. Aging 2001, 22:937-944.
31. Heneka M.T., Gavrilyuk V., Landreth G.E., O'Banion M.K., Weinberg G., Feinstein D.L. Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J. Neurochem. 2003, 85:387-398.
32. Reusch J.E., Begum N., Sussman K.E., Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 1991, 129:3269-3273.
33. Draznin B., Sussman K., Kao M., Lewis D., Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J. Biol. Chem. 1987, 262:14385-14388.
34. Deyo R.A., Straube K.T., Disterhoft J.F. Nimodipine facilitates associative learning in aging rabbits. Science 1989, 243:809-811.
35. Thibault O., Gant J.C., Landfield P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007, 6:307-317.
36. Disterhoft J.F., Thompson L.T., Moyer J.R., Mogul D.J. Calcium-dependent after hyperpolarization and learning in young and aging hippocampus. Life Sci. 1996, 59:413-420.
37. Thibault O., Landfield P.W. Increase in single L-type calcium channels in hippocampal neurons during aging. Science 1996, 272:1017-1020.
38. Foster T.C., Sharrow K.M., Masse J.R., Norris C.M., Kumar A. Calcineurin links Ca2+ dysregulation with brain aging. J. Neurosci. 2001, 21:4066-4073.
39. Toescu E.C., Verkhratsky A. The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging. Aging Cell 2007, 6:267-273.
40. Yamada K., Nakata M., Horimoto N., Saito M., Matsuoka H., Inagaki N. Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic beta-cells. J. Biol. Chem. 2000, 275:22278-22283.
41. Yoshioka K., Saito M., Oh K.B., Nemoto Y., Matsuoka H., Natsume M., Abe H. Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells. Biosci. Biotechnol. Biochem. 1996, 60:1899-1901.
42. Natarajan A., Srienc F. Dynamics of glucose uptake by single Escherichia coli cells. Metab. Eng. 1999, 1:320-333.
43. Bittner C.X., Valdebenito R., Ruminot I., Loaiza A., Larenas V., Sotelo-Hitschfeld T., Moldenhauer H., San Martin A., Gutierrez R., Zambrano M., Barros L.F. Fast and reversible stimulation of astrocytic glycolysis by k+ and a delayed and persistent effect of glutamate. J. Neurosci. 2011, 31:4709-4713.
44. Chuquet J., Quilichini P., Nimchinsky E.A., Buzsaki G. Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. J. Neurosci. 2010, 30:15298-15303.
45. Porras O.H., Loaiza A., Barros L.F. Glutamate mediates acute glucose transport inhibition in hippocampal neurons. J. Neurosci. 2004, 24:9669-9673.
46. Barros L.F., Courjaret R., Jakoby P., Loaiza A., Lohr C., Deitmer J.W. Preferential transport and metabolism of glucose in Bergmann glia over Purkinje cells: a multiphoton study of cerebellar slices. Glia 2009, 57:962-970.
47. Porter N.M., Thibault O., Thibault V., Chen K.C., Landfield P.W. Calcium channel density and hippocampal cell death with age in long-term culture. J. Neurosci. 1997, 17:5629-5639.
48. Itoh Y., Abe T., Takaoka R., Tanahashi N. Fluorometric determination of glucose utilization in neurons in vitro and in vivo. J. Cereb. Blood Flow Metab. 2004, 24:993-1003.
49. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
50. Schmidt M.M., Dringen R. Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes. Front. Neuroenerg. 2009, 1:1.
51. Maher F., Davies-Hill T.M., Lysko P.G., Henneberry R.C., Simpson I.A. Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3. Mol. Cell. Neurosci. 1991, 2:351-360.
52. Maher F., Davies-Hill T.M., Simpson I.A. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem. J. 1996, 315(Pt 3):827-831.
53. Simpson I.A., Carruthers A., Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007, 27:1766-1791.
54. Abe T., Takahashi S., Suzuki N. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of d-aspartate or potassium stimulation. J. Cereb. Blood Flow Metab. 2006, 26:153-160.
55. Benjamin A.M., Verjee Z.H. Control of aerobic glycolysis in the brain in vitro. Neurochem. Res. 1980, 5:921-934.
56. Magistretti P.J. Role of glutamate in neuron-glia metabolic coupling. Am. J. Clin. Nutr. 2009, 90:875S-880S.
57. Shuttleworth C.W. Use of NAD(P)H and flavoprotein autofluorescence transients to probe neuron and astrocyte responses to synaptic activation. Neurochem. Int. 2010, 56:379-386.
58. Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta 1998, 1364:222-235.
59. Kasischke K.A., Vishwasrao H.D., Fisher P.J., Zipfel W.R., Webb W.W. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 2004, 305:99-103.
60. Shuttleworth C.W., Brennan A.M., Connor J.A. NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. J. Neurosci. 2003, 23:3196-3208.
61. Galea E., Feinstein D.L., Lacombe P. Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. Diabetologia 2006, 49:2153-2161.
62. Izawa Y., Takahashi S., Suzuki N. Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia. Brain Res. 2009, 1305:64-73.
63. Whitesell R.R., Ward M., McCall A.L., Granner D.K., May J.M. Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate-limiting step. J. Cereb. Blood Flow Metab. 1995, 15:814-826.
64. Yi K.D., Chung J., Pang P., Simpkins J.W. Role of protein phosphatases in estrogen-mediated neuroprotection. J. Neurosci. 2005, 25:7191-7198.
65. Lai J.C., Behar K.L., Liang B.B., Hertz L. Hexokinase in astrocytes: kinetic and regulatory properties. Metab. Brain Dis. 1999, 14:125-133.
66. Rust R.S., Carter J.G., Martin D., Nerbonne J.M., Lampe P.A., Pusateri M.E., Lowry O.H. Enzyme levels in cultured astrocytes, oligodendrocytes and Schwann cells, and neurons from the cerebral cortex and superior cervical ganglia of the rat. Neurochem. Res. 1991, 16:991-999.
67. Theodosis D.T., Poulain D.A., Oliet S.H. Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. Physiol. Rev. 2008, 88:983-1008.
68. Takahashi S., Driscoll B.F., Law M.J., Sokoloff L. Role of sodium and potassium ions in regulation of glucose metabolism in cultured astroglia. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:4616-4620.
69. Brown A.M., Ransom B.R. Astrocyte glycogen and brain energy metabolism. Glia 2007, 55:1263-1271.
70. DiNuzzo M., Mangia S., Maraviglia B., Giove F. Glycogenolysis in astrocytes supports blood-borne glucose channeling not glycogen-derived lactate shuttling to neurons: evidence from mathematical modeling. J. Cereb. Blood Flow Metab. 2010, 30:1895-1904.
71. Begum N., Leitner W., Reusch J.E., Sussman K.E., Draznin B. GLUT-4 phosphorylation and its intrinsic activity. Mechanism of Ca(2+)-induced inhibition of insulin-stimulated glucose transport. J. Biol. Chem. 1993, 268:3352-3356.
72. Draznin B., Lewis D., Houlder N., Sherman N., Adamo M., Garvey W.T., LeRoith D., Sussman K. Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology 1989, 125:2341-2349.
73. Porras O.H., Ruminot I., Loaiza A., Barros L.F. Na(+)-Ca(2+) cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes. Glia 2008, 56:59-68.
74. Quintanilla R.A., Porras O.H., Castro J., Barros L.F. Cytosolic [Ca(2+)] modulates basal GLUT1 activity and plays a permissive role in its activation by metabolic stress and insulin in rat epithelial cells. Cell Calcium 2000, 28:97-106.
75. Bihler I., Charles P., Sawh P.C. Role of calcium in the regulation of sugar transport in the avian erythrocyte: effects of the calcium ionophore, A23187. Cell Calcium 1982, 3:243-262.
76. 2+-dependent translocation of hexose carrier in mouse fibroblast Swiss 3T3 cells. Biochim. Biophys. Acta 1987, 928:272-281.
77. Cheung J.Y., Constantine J.M., Bonventre J.V. Cytosolic free calcium concentration and glucose transport in isolated cardiac myocytes. Am. J. Physiol. 1987, 252:C163-C172.
78. Klip A., Li G., Logan W.J. Role of calcium ions in insulin action on hexose transport in L6 muscle cells. Am. J. Physiol. 1984, 247:E297-E304.
79. Kahlert S., Zundorf G., Reiser G. Glutamate-mediated influx of extracellular Ca2+ is coupled with reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes. J. Neurosci. Res. 2005, 79:262-271.
80. Herrero-Mendez A., Almeida A., Fernandez E., Maestre C., Moncada S., Bolanos J.P. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 2009, 11:747-752.
81. Madrigal J.L., Kalinin S., Richardson J.C., Feinstein D.L. Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J. Neurochem. 2007, 103:2092-2101.
82. Fuenzalida K., Quintanilla R., Ramos P., Piderit D., Fuentealba R.A., Martinez G., Inestrosa N.C., Bronfman M. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J. Biol. Chem. 2007, 282:37006-37015.
83. Hunter R.L., Choi D.Y., Ross S.A., Bing G. Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats. Neurosci. Lett. 2008, 432:198-201.
84. Sauerbeck A., Gao J., Readnower R., Liu M., Pauly J.R., Bing G., Sullivan P. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp. Neurol. 2011, 227:128-135.
85. el-Kebbi I.M., Roser S., Pollet R.J. Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 1994, 43:953-958.
86. Shimaya A., Kurosaki E., Shioduka K., Nakano R., Shibasaki M., Shikama H. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Horm. Metab. Res. 1998, 30:543-548.
87. Thibault O., Hadley R., Landfield P.W. Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J. Neurosci. 2001, 21:9744-9756.
88. Rowe W.B., Blalock E.M., Chen K.C., Kadish I., Wang D., Barrett J.E., Thibault O., Porter N.M., Rose G.M., Landfield P.W. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J. Neurosci. 2007, 27:3098-3110.
89. Benedict C., Hallschmid M., Schmitz K., Schultes B., Ratter F., Fehm H.L., Born J., Kern W. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 2007, 32:239-243.
90. Reger M.A., Watson G.S., Frey W.H., Baker L.D., Cholerton B., Keeling M.L., Belongia D.A., Fishel M.A., Plymate S.R., Schellenberg G.D., Cherrier M.M., Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 2006, 27:451-458.